Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Pyrimethamine |
Synonyms | |
Therapy Description |
Daraprim (pyrimethamine) inhibits DHFR, potentially leading to cell cycle arrest and decreased proliferation of tumor cells and inhibition of tumor growth (PMID: 35262820, PMID: 34921584). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pyrimethamine | Daraprim | Daraprim (pyrimethamine) inhibits DHFR, potentially leading to cell cycle arrest and decreased proliferation of tumor cells and inhibition of tumor growth (PMID: 35262820, PMID: 34921584). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05678348 | Phase I | Pyrimethamine | Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma | Recruiting | USA | 0 |